Retatrutide is a new medication in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in investigations. By activating these receptors, https://pennyzzpx024394.blogars.com/35049043/retatrutide-a-promising-new-treatment-for-obesity